Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
10%+ Owner
-
Stock Symbol
-
JANX on Nasdaq
Jay Lichter - trading volume in the past year for Janux Therapeutics, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
3.02M |
$135M |
$44.75 |
Sep 13, 2024 |
By Avalon BioVentures SPV I, L.P. |
|
|
Common Stock |
2.96M |
$132M |
$44.75 |
Sep 13, 2024 |
By Avalon Ventures XI, L.P. |
|
|
Common Stock |
573K |
$25.7M |
$44.75 |
Sep 13, 2024 |
By Avalon BioVentures I, LP |
|
|
Common Stock |
7K |
$327K |
$46.68 |
Sep 13, 2024 |
Direct |
|
|
Stock Option (right to buy) |
7.68K |
|
|
Sep 13, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.